C3 Glomerulopathy: Pathogenesis and Treatment
Advances in Chronic Kidney Disease · 2020-03 · 27 (2) · 104-110
DOI: 10.1053/j.ackd.2019.12.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Chronic Kidney Disease, 2020-03. Verfasst von Syeda Behjat Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY. Hauptthemen laut MEDLINE: Complement Inactivating Agents, Complement Pathway, Alternative, Glomerulonephritis, Membranoproliferative. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
- Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY. Electronic address: asb68@cumc.columbia.edu.
Zitieren
APA
Ahmad, S. B., & Bomback, A. S. (2020). C3 Glomerulopathy: Pathogenesis and Treatment. Advances in Chronic Kidney Disease, 27(2), 104-110. https://doi.org/10.1053/j.ackd.2019.12.003
Vancouver
Ahmad SB, Bomback AS. C3 Glomerulopathy: Pathogenesis and Treatment. Advances in Chronic Kidney Disease. 2020;27(2):104-110. doi:10.1053/j.ackd.2019.12.003
BibTeX
@article{Ahmad2020,
author = {Ahmad, Syeda Behjat and Bomback, Andrew S},
title = {C3 Glomerulopathy: Pathogenesis and Treatment},
journal = {Advances in Chronic Kidney Disease},
year = {2020},
volume = {27},
number = {2},
pages = {104--110},
doi = {10.1053/j.ackd.2019.12.003}
}
EUVIMED